Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (451-460 of 620) with videos related to

Pageof 62
Sort By:
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
The Neurologist|September 2, 2011
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topicAmaal J Starling, Charlene Hoffman-Snyder, Rashmi B Halker, et al.
Pain|January 10, 2023
Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic primingCaroline M Kopruszinski, Moe Watanabe, Ashley L Martinez, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Headache|December 16, 2020
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment StudyRichard B Lipton, Dawn C Buse, David W Dodick, et al.
Headache|May 20, 2011
OnabotulinumtoxinA for treatment of chronic migraine: a responseDavid W Dodick, Catherine C Turkel, Ronald E Degryse, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.
Headache|March 21, 2023
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial dataDavid Kudrow, Rima Dafer, David W Dodick, et al.
Pageof 62

Showing results (451-460 of 620) with videos related to

Sort By:
Pageof 62
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
The Neurologist|September 2, 2011
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topicAmaal J Starling, Charlene Hoffman-Snyder, Rashmi B Halker, et al.
Pain|January 10, 2023
Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic primingCaroline M Kopruszinski, Moe Watanabe, Ashley L Martinez, et al.
Headache|February 18, 2021
Systematic review of outcomes and endpoints in preventive migraine clinical trialsJames S McGinley, Carrie R Houts, Tracy K Nishida, et al.
Headache|February 21, 2021
Systematic review of outcomes and endpoints in acute migraine clinical trialsCarrie R Houts, James S McGinley, Tracy K Nishida, et al.
Headache|December 16, 2020
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment StudyRichard B Lipton, Dawn C Buse, David W Dodick, et al.
Headache|May 20, 2011
OnabotulinumtoxinA for treatment of chronic migraine: a responseDavid W Dodick, Catherine C Turkel, Ronald E Degryse, et al.
Neurology|August 25, 2017
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label studyMessoud Ashina, David Dodick, Peter J Goadsby, et al.
Headache|September 2, 2009
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measuresStephen Silberstein, Richard Lipton, David Dodick, et al.
Headache|March 21, 2023
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial dataDavid Kudrow, Rima Dafer, David W Dodick, et al.
Pageof 62